Showing results (51-60 of 443) with videos related to
Sort By:
Pageof 45
Bone Marrow Transplantation|January 29, 2025
Relationship between age, conditioning intensity, and outcome after allografting in adults age ≥60 years with AMLPhuong T Vo, Brenda M Sandmaier, Megan Othus, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantationChirag R Parikh, Robert W Schrier, Barry Storer, et al.Seminars in Oncology|February 19, 2004
Targeted cancer therapy and immunosuppression using radiolabeled monoclonal antibodiesWolfgang A Bethge, Brenda M SandmaierExpert Review of Vaccines|December 21, 2004
Vaccination with Theratope (STn-KLH) as treatment for breast cancerLeona A Holmberg, Brenda M SandmaierHematology. American Society of Hematology. Education Program|November 25, 2006
Outcomes with myeloid malignanciesBart L Scott, Brenda M SandmaierTechnology in Cancer Research & Treatment|July 21, 2005
Targeted cancer therapy using radiolabeled monoclonal antibodiesWolfgang A Bethge, Brenda M SandmaierCurrent Opinion in Hematology|October 10, 2013
Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomesAndrew R Rezvani, Brenda M SandmaierBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapyAjay K Gopal, John M Pagel, Joseph G Rajendran, et al.British Journal of Haematology|February 18, 2011
Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of ageScott Samuelson, Brenda M Sandmaier, Helen E Heslop, et al.Pageof 45